Natural history and prognostic factors for chronic hepatitis type B

G Fattovich1, L Brollo, G Giustina

  • 1Istituto di Medicina Clinica, Clinica Medica 2, Università di Padova, Italy.

Gut
|March 1, 1991
PubMed

Insights

Patients with chronic hepatitis B infection who have severe liver inflammation and active hepatitis B virus DNA replication face a high risk of developing cirrhosis. Early detection and monitoring are crucial for managing this progressive liver disease.

Area of Science:

  • Hepatology
  • Virology
  • Gastroenterology

Background:

  • Chronic hepatitis B virus (HBV) infection affects millions globally.
  • Progression to cirrhosis is a major complication of chronic hepatitis B.
  • Identifying risk factors for cirrhosis development is critical for patient management.

Purpose of the Study:

  • To determine the incidence and risk factors for cirrhosis development in patients with chronic hepatitis B.
  • To identify predictors of rapid progression to cirrhosis in this patient cohort.

Main Methods:

  • Longitudinal follow-up of 105 HBsAg-positive patients with chronic persistent or chronic active hepatitis.
  • Regular clinical and histological assessments, including follow-up liver biopsies.
  • Statistical analysis using Cox multiple regression to identify independent prognostic factors.

Main Results:

  • 20% of patients developed cirrhosis over a mean follow-up of 3.7 years (annual incidence 5.9%).
  • Higher risk of cirrhosis was observed in patients with chronic active hepatitis and bridging hepatic necrosis compared to chronic persistent hepatitis.
  • Older age, bridging hepatic necrosis, and persistent HBV DNA in serum were independent predictors of poor prognosis.

Conclusions:

  • Severe chronic active hepatitis and persistent HBV replication significantly increase the risk of rapid cirrhosis development.
  • Prognostic factors like bridging hepatic necrosis and HBV DNA persistence can guide clinical monitoring and intervention strategies.
  • This study highlights the importance of risk stratification for patients with chronic hepatitis B to prevent advanced liver disease.

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...